Burroughs Wellcome Co.
Records under this name other than patents Burroughs Wellcome Co. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Burroughs Wellcome Co.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,479,283 | Acellular pertussis vaccine comprising a combination of the 69 kDa and the filamentous haemagglutinin antigens of Bordetella pertussis Formerly held Term ended Term ended Jan 20, 2026 · From the USPTO record | Term ended | Term ended Jan 20, 2026 | From the USPTO record |
| US 7,098,006 | Chimeric antibody, pharmaceutical composition and process of its production Term ended Term ended Aug 29, 2023 · From the USPTO record | Term ended | Term ended Aug 29, 2023 | From the USPTO record |
| US 6,268,374 | Uracil reductase inactivators Formerly held Term ended Term ended Jul 31, 2018 · From the USPTO record | Term ended | Term ended Jul 31, 2018 | From the USPTO record |
| US 6,210,675 | PT-NANB hepatitis polypeptides Formerly held Term ended Term ended Apr 3, 2018 · From the USPTO record | Term ended | Term ended Apr 3, 2018 | From the USPTO record |
| US 6,127,151 | Antigenic preparations and the isolation of such preparations Formerly held Term ended Term ended Oct 3, 2017 · From the USPTO record | Term ended | Term ended Oct 3, 2017 | From the USPTO record |
| US 6,048,700 | Antigenic preparations and the isolation of such preparations Formerly held Term ended Term ended Apr 11, 2017 · From the USPTO record | Term ended | Term ended Apr 11, 2017 | From the USPTO record |
| US 6,045,790 | Vaccines for equine influenza Formerly held Term ended Term ended Apr 4, 2017 · From the USPTO record | Term ended | Term ended Apr 4, 2017 | From the USPTO record |
| US 6,177,435 | Therapeutic combinations Formerly held Term ended Term ended Mar 20, 2017 · From the USPTO record | Term ended | Term ended Mar 20, 2017 | From the USPTO record |
| US 6,383,498 | Compositions for vaccines Formerly held Lapsed on the fee record Ended May 7, 2014 · From the USPTO record | Lapsed on the fee record | Ended May 7, 2014 | From the USPTO record |
| US 7,119,096 | Uracil Reductase Inactivators Formerly held Term ended Term ended Mar 26, 2014 · Medium confidence | Term ended | Term ended Mar 26, 2014 | Medium confidence |